Safety and Efficacy of MP-424 to Treat Chronic Hepatitis C
NCT00621296
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis C
Interventions
DRUG:
MP-424 (Telaprevir)
Sponsor
Tanabe Pharma Corporation
Collaborators
Vertex Pharmaceuticals Incorporated